Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Randomized, Double-Blinded, Pilot Trial of Neoadjuvant Checkpoint Inhibition followed by Combination Adjuvant Checkpoint Inhibition in Children and Young Adults with Recurrent or Progressive High Grade Glioma (HGG)
Protocol ID
PNOC 0019
Disease (Sub Disease)
Brain and Spinal Tumours (High Grade Gliomas)
Diagnosis Stage
Relapsed/ refractory
Location
WA
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Pacific Pediatric Neuro-Oncology Consortium
Collaborators
Bristol-Myers Squibb
Trial Status
Open
Sites
Perth Children's Hospital
Study Type
Treatment
Phase
Pilot
Age Eligibility
6 Months to 22 Years
International registry ID's
NCT04323046
Back to Registry
Study Title A Randomized Double-Blinded Pilot Trial of Neoadjuvant Checkpoint Inhibition followed by Combination Adjuvant Checkpoint Inhibition in Children and Young Adults with Recurrent or Progressive High Grade Glioma (HGG)
Protocol ID PNOC 0019
Disease (Sub Disease) Brain and Spinal Tumours (High Grade Gliomas)
Diagnosis Stage Relapsed/ refractory
Location WA
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ Pacific Pediatric Neuro-Oncology Consortium
Collaborators Bristol-Myers Squibb
Links https://clinicaltrials.gov/ct2/show/NCT04323046
Trial Status Open
Trial Open Date 01/03/2021
Sites Perth Children's Hospital
Study Type Treatment
Phase Pilot
Age Eligibility 6 Months to 22 Years
International registry ID's NCT04323046